BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
Loading
Cash spent on acquiring or upgrading physical assets
Latest
$-2.47M
↓ 51% vs avg
Percentile
P14
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-1.63M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-2.47M | -119.6% |
| 2024 | $-1.12M | +48.2% |
| 2023 | $-2.17M | -60.5% |
| 2022 | $-1.35M | +43.4% |
| 2021 | $-2.38M | -364.0% |
| 2020 | $-514000.00 | -49.9% |
| 2019 | $-343000.00 | +6.3% |
| 2018 | $-366000.00 | -11.6% |
| 2017 | $-328000.00 | +93.8% |
| 2016 | $-5.28M | - |